- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 146.29M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $3.18B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $3.18B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $588.14M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $593.67M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $793.59M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $711.36M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $4.33B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $4.25B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.1B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.03B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $7.18B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $7.14B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 150.92M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $10.05M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $18.06M |
| Capex | Q1 2025 · Mar 31, 2024 | $42.13M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $106.49M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $2.97B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $3B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.50 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.51 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $88.05M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $45.31M |
| Net Income | Q1 2025 · Mar 31, 2024 | $76.02M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $144.79M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $689.26M |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.01B |